Suchergebnisse - "Halpin, David M G"

PubPharm (191)

91

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

enthalten in: Respiratory research | 2020

von Rabe, K. | Halpin, D. | Han, M. | +5

92

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

enthalten in: Advances in therapy | 2020

von Tabberer, M. | Jones, C. | Kilbride, S. | +12

93

Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities : A Post Hoc Analysis

enthalten in: Pulmonary therapy | 2020

von Halpin, D. | Hamelmann, E. | Frith, P. | +5

94

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

enthalten in: American journal of respiratory and critical care medicine | 2020

von Lipson, D. | Crim, C. | Criner, G. | +17

CommentIn: Am J Respir Crit Care Med. 2020 Jun 15;201(12):1463-1464. - PMID 32212973

95

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial

enthalten in: Respiratory research | 2020

von Day, N. | Kumar, S. | Criner, G. | +13

96

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

enthalten in: Respiratory research | 2020

von Day, N. | Kumar, S. | Criner, G. | +13

97

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

enthalten in: Respiratory research | 2020

von Day, N. | Kumar, S. | Criner, G. | +13

98

The effect of exacerbation history on outcomes in the IMPACT trial

enthalten in: The European respiratory journal | 2020

von Halpin, D. | Dransfield, M. | Han, M. | +10

CommentIn: Eur Respir J. 2020 May 21;55(5):. - PMID 32439736

99

Inhaled corticosteroids and COVID-19 : a systematic review and clinical perspective

enthalten in: The European respiratory journal | 2020

von Halpin, D. | Singh, D. | Hadfield, R.

100

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

enthalten in: The Lancet. Respiratory medicine | 2020

von Halpin, D. | Faner, R. | Sibila, O. | +2